About Hello Practice Scribe
- Released
- Updated
- iOS Version
- Age Rating
- Size
- Devices
- Languages
Features
Developer of Hello Practice Scribe
What's New in Hello Practice Scribe
1.1.0
November 10, 2024
Minor bug fixes
Alternatives to Hello Practice Scribe
More Applications by HelloPractice, Inc.
FAQ
Is Hello Practice Scribe compatible with iPad devices?
No, Hello Practice Scribe doesn’t work on iPad devices.
Who is the creator of the Hello Practice Scribe app?
HelloPractice, Inc. is the creator of the Hello Practice Scribe app.
What is the minimum iOS version supported by Hello Practice Scribe?
The minimum supported iOS version for the Hello Practice Scribe app is iOS 14.0.
How do users rate the app?
The Hello Practice Scribe app has received no user ratings yet.
What is the primary genre of the Hello Practice Scribe app?
The Primary Genre Of The Hello Practice Scribe App Is Health & Fitness.
What is the recent version of the Hello Practice Scribe app?
1.1.0 is the newly released Hello Practice Scribe version.
When was the latest Hello Practice Scribe update?
The latest Hello Practice Scribe update was rolled out on January 6, 2025.
When was the Hello Practice Scribe app released?
The Hello Practice Scribe app launched on July 2, 2024.
What is the content advisory rating of the Hello Practice Scribe app?
The Hello Practice Scribe app contains no objectionable material and is suitable for children aged HelloPractice, Inc..
What languages does Hello Practice Scribe support?
You can use the Hello Practice Scribe app in American English.
Is Hello Practice Scribe available in Apple Arcade's lineup?
No, Hello Practice Scribe is not available on Apple Arcade.
Are there in-app purchases available in Hello Practice Scribe?
No, Hello Practice Scribe does not offer in-app purchases.
Does Hello Practice Scribe support Apple Vision Pro compatibility?
No, Hello Practice Scribe does not support compatibility with Apple Vision Pro.
Does Hello Practice Scribe display any ads?
No, Hello Practice Scribe does not display any ads.